[Form 4] The Vita Coco Company, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Vita Coco Company director Ira Liran reported sales of common stock under a Rule 10b5-1 trading plan. On 09/03/2025 he disposed of 14,734 shares at a weighted-average price of $37.052 per share and on 09/04/2025 he disposed of 2,114 shares at a weighted-average price of $37.001 per share, for a total of 16,848 shares sold. Following these transactions the filing shows 618,341 shares held directly and 782,579 shares held indirectly through the Ira Liran 2012 Family Trust. The filing was signed by Alison Klein, attorney-in-fact, on 09/05/2025.

Positive

• Sales executed under a Rule 10b5-1 plan, which provides an affirmative defense against insider trading timing concerns
• Clear disclosure of post-transaction ownership: 618,341 shares direct and 782,579 shares indirect via the Ira Liran 2012 Family Trust
• Weighted-average prices disclosed and footnotes commit to provide breakdowns by execution price on request

Negative

• Director disposed of 16,848 shares (14,734 on 09/03/2025 and 2,114 on 09/04/2025), representing insider selling activity
• Sales reduce direct holdings from prior levels (now 618,341 direct), which may be viewed negatively by some investors

Insights

Financial Analyst

TL;DR: Director executed preplanned sales totaling 16,848 shares at ~ $37 each; holdings remain substantial both directly and via trust.

The reported disposals were executed pursuant to a Rule 10b5-1 plan, which reduces timing-based signaling but still represents insider selling of 16,848 shares across two days at weighted-average prices of $37.052 and $37.001. Post-transaction holdings show 618,341 shares direct and 782,579 indirect via a family trust, indicating continued meaningful economic ownership. For investors, this is routine insider liquidity rather than a change in control or a corporate action.

Corporate Governance Expert

TL;DR: Disclosure is timely and documents use of a 10b5-1 plan; documentation appears procedurally compliant.

The Form 4 clearly states the sales were effected under a Rule 10b5-1 trading plan and provides weighted-average price ranges for the transactions. The filing lists direct and indirect ownership and is signed by an attorney-in-fact, reflecting appropriate procedural steps for Section 16 reporting. No amendments or additional governance events are disclosed in this form.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Liran Ira

(Last) (First) (Middle)

250 PARK AVE SOUTH

SEVENTH FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/03/2025		S(1)		14,734	D	$37.052(2)	620,455	D
Common Stock	09/04/2025		S(1)		2,114	D	$37.001(3)	618,341	D
Common Stock								782,579	I	by Ira Liran 2012 FT(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.14, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.02, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

4. These shares are held by the Ira Liran 2012 Family Trust.

	By: Alison Klein, Attorney-In Fact For: Ira Liran	09/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Ira Liran report on the Form 4 for COCO?

Ira Liran reported sales of 14,734 shares on 09/03/2025 and 2,114 shares on 09/04/2025 under a Rule 10b5-1 plan.

How many shares does Ira Liran beneficially own after the reported transactions?

He holds 618,341 shares directly and 782,579 shares indirectly through the Ira Liran 2012 Family Trust.

At what prices were the shares sold?

The weighted-average prices were $37.052 for the 09/03/2025 sales and $37.001 for the 09/04/2025 sales; execution ranges are disclosed in footnotes.

Were these sales part of a prearranged plan?

Yes. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan.

Who signed the Form 4 and when?

The form was signed by Alison Klein, attorney-in-fact for Ira Liran, on 09/05/2025.